Results 61 to 70 of about 9,802 (262)

The chimeric ALT-vastus lateralis free flap in reconstruction of advanced BRONJ of the maxilla. [PDF]

, 2015
Introduction Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a dangerous complication of bisphosphonates, a class of pharmaceutical agents used in numerous bone disor- ders.
CILLINO, Michele, CORDOVA, Adriana, D'ARPA, Salvatore, DI LORENZO, Sara, Santanelli di Pompeo, F, TOIA, Francesca   +5 more
core   +1 more source

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study

Heliyon, 2023
Background: Leukocyte- and platelet-rich fibrin (L-PRF) could be considered a preventive measure in Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Milad Etemadi Sh, Farnaz Shooshtarian, Golnaz Tajmiri, MohammadSoroush Sehat   +3 more
doaj   +1 more source

Seven Cases of Bisphosphonate-Associated Osteonecrosis of the Jaw

Dental Medicine Research, 2008
Osamu INOUE, Takahiko Toyoshima, Shiho Maruyama, Chigusa MOCHIDA, Hitoshi WATANABE, Masaru Ohashi, Tatsuo Shirota, Masashi Hatori, Satoru Shintani   +8 more
openalex   +3 more sources

Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking

Journal of Applied Oral Science, 2015
Objective There is strong evidence of a link between the use of systemic bisphosphonates (BPs) and osteonecrosis of the jaw, especially in cancer patients.
Arezo TARDAST, Reine SJÖMAN, Sigbjørn LØES, Jahan ABTAHI   +3 more
doaj   +1 more source

The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

BMC Oral Health, 2021
Background Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of
A. Lum Han
doaj   +1 more source

Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat [PDF]

, 2018
OBJECTIVES: Pathogenesis of bisphosphonate-related osteonecrosis of the jaws (BRONJ) is not fully explained. An antiangiogenic effect of bisphosphonates (BPs) or an altered bone quality have been advocated.
D. Chappard, F. Pascaretti-Grizon, G. Mabilleau, H. Marchand-Libouban, J.D. Kün-Darbois   +4 more
core   +1 more source

Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws: a review of the literature [PDF]

, 2016
Background: Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely prescribed for the treatment of osteoporosis and are also used in patients with multiple myeloma and metastatic breast or prostate cancer for avoiding bone ...
Bagán Sebastián, José Vicente, Gavaldá Esteve, Carmen   +1 more
core   +1 more source

Dental treatment considerations in the chemotherapy patient [PDF]

, 2011
Cancer patients can suffer oral toxic effects secondary to antineoplastic therapy in the form of radiotherapy and/ or chemotherapy. This risk is conditioned by a range of factors, including the high cell turnover rate of the oral mucosa, the diversity ...
Chaveli López, Begonya, Gavaldá Esteve, Carmen, Sarrión Pérez, María Gracia   +2 more
core   +1 more source

Rescuing Mitochondrial Dysfunction in Macrophages Prevents Osteonecrosis of the Jaw in Anti‐Resorptive Therapy

Advanced Science, EarlyView.
Schematic model showing the suggested mechanism that ZA induces classical activation of macrophages by impairing mitochondrial biofunction and inhibiting mitochondrial clearance to contribute to the pathological process of BRONJ. RAPA‐loaded nanoparticles ZDPR has shown potential in alleviating BRONJ lesions as well as treating osteoporosis or ...
Hang Zhang, Xin Shen, Haiyang Liu, Xinxi Yuan, Mumin Cao, Xuepeng Lv, Ziji Ling, Songsong Guo, Rongyao Xu, Xiang Li, Hongbing Jiang   +10 more
wiley   +1 more source

Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review

Frontiers in Oral Health
IntroductionMedication-related osteonecrosis of the Jaw (MRONJ) is an adverse drug reaction that affects the mandible and maxilla of patients exposed to BMA and AA therapies, causing the progressive destruction and death of bone.
Rodolfo Mauceri, Rodolfo Mauceri, Sonia Arduini, Martina Coppini, Martina Coppini, Martina Coppini, Monica Bazzano, Isabel Trujillo, Giuseppina Campisi   +8 more
doaj   +1 more source